| For: | Mondal S, Pramanik S, Khare VR, Fernandez CJ, Pappachan JM. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives. World J Cardiol 2024; 16(5): 240-259 [PMID: 38817648 DOI: 10.4330/wjc.v16.i5.240] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i5/240.htm |
| Number | Citing Articles |
| 1 |
Ahmed Essam Abou Warda, Sarah Sabry Hashem Nafea, Mohamed Nabil Salem, Heba F. Salem, Ayman N. Moharram, Sayed Gaber, Kerolus Kamel Megalaa, Bassem Zarif, Rania M. Sarhan. The Emerging Role of Dapagliflozin in Right Ventricular Dysfunction and Pulmonary Hypertension in Patients with Heart Failure with Reduced and Mildly Reduced Ejection Fraction. Journal of Pharmaceutical Innovation 2027; 22(1) doi: 10.1007/s12247-026-10981-5
|
| 2 |
Murali Krishna Moka, Melvin George, Deepalaxmi Rathakrishnan, V Jagadeeshwaran, Sriram D K. Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations. Current Research in Translational Medicine 2025; 73(2) doi: 10.1016/j.retram.2025.103496
|
| 3 |
Saheed E. Sanyaolu, Diana O. Wilson, Blessing A. Oguntolu, Mautin S. Salako, Rukayat O. Adeyemi. Current Evidence on the Clinical Management of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. Premier Journal of Cardiology 2025; doi: 10.70389/PJC.100011
|
| 4 |
Ricardo Caballero, Juan Tamargo, Eva Delpón. SGLT2 inhibitors: Do they have antiarrhythmic properties?. Pharmacology & Therapeutics 2026; 279 doi: 10.1016/j.pharmthera.2025.108973
|
| 5 |
Rebecca Ayoti, Zahid Khan, Gideon Mlawa, Animesh Gupta. Assessing the Effectiveness and Safety of Combination Diuretic Therapy in Heart Failure: A Systematic Review and Meta-Analysis. Cureus 2024; doi: 10.7759/cureus.72118
|
| 6 |
Takefumi Kishimori, Takao Kato, Atsuyuki Wada, Akira Tani, Ryosuke Yamaji, Jumpei Koike, Yoshihiro Iwasaki, Takahiro Matsumoto, Takafumi Yagi, Masaharu Okada. Combination therapy with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in heart failure patients with type 2 diabetes. BMJ Open Diabetes Research & Care 2025; 13(6) doi: 10.1136/bmjdrc-2025-005364
|
| 7 |
Jenny Lue Solomon, Julie Piccione, Shelly Gulkarov, Ankita Srivastava, Joshua De Leon, Elise Belilos, Steven E. Carsons, Allison B. Reiss. Inflammation. 2026; doi: 10.1007/978-3-031-55254-0_24-1
|
| 8 |
Xiangling Duan, Xiaomeng Zhang, Bao Sun. The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02750-4
|
| 9 |
Yu-Ning Hou, Shu-Jing Liu, Liang-Ming Li. GPR75: A dual-ligand receptor for 20-HETE and CCL5 with emerging roles in central and peripheral regulation of metabolic diseases. Pharmacological Research 2026; 233 doi: 10.1016/j.phrs.2026.108452
|
| 10 |
Xinyue Zhang, Yanxia Zhang, Jiayu Wang, Zhijia Tang. Sodium-glucose cotransporter 2 inhibitors in the treatment of heart failure patients: A systematic review and meta-analysis of cost-utility studies. Archives of Gerontology and Geriatrics 2025; 133 doi: 10.1016/j.archger.2025.105809
|
| 11 |
Elena Y. Rykova, Vadim V. Klimontov, Elena Shmakova, Anton I. Korbut, Tatyana I. Merkulova, Julia Kzhyshkowska. Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages. International Journal of Molecular Sciences 2025; 26(4) doi: 10.3390/ijms26041670
|
| 12 |
Elena E. Korbolina, Maria Gubina, Leonid O. Bryzgalov, Arina O. Degtyareva, Anastasia A. Evseenko, Elena V. Antonseva, Anton I. Korbut, Elena Y. Rykova, Vadim V. Klimontov, Julia G. Kzhyshkowska, Tatiana I. Merkulova. Analysis of Allele-Specific Expression Highlights Novel Participants of Empagliflozin-Driven Effects on T2DM-Associated Regulatory Pathways. International Journal of Molecular Sciences 2026; 27(16) doi: 10.3390/ijms27167202
|
| 13 |
Samar Abed Alharbi, Amal Ahmad Alsubaiei, Ali Hussain Alkhalifah, Abdulrahman Abdulaziz Alshehri, Shoog Soliman Alhaggas, Shahad Marwan Alhuthli, Yousef Hassan Alfaqih, Wed Ziyad Alnajjar, Ghaida Abdulla Alshaban, Mahmood Sameer Ahmed, Abdulkarem Sarhan Alqarni. The role of SGLT2 inhibitors in protecting cardiovascular health: beyond glycaemic control. International Journal Of Community Medicine And Public Health 2025; doi: 10.18203/2394-6040.ijcmph20250050
|